Biocon Biologics, RSSDI collaborate to expand access to insulins for diabetic kids Ruchika Sharma15 Nov 2021 4:12 PM ISTBengaluru: Biocon Biologics Limited, a subsidiary of Biocon Ltd., today announced that it has tied up with the Research Society for the Study of...
Biocon Biologics, Viatris interchangeable biosimilar Insulin Glargine preferred on Express Scripts' largest formulary in US Ruchika Sharma21 Oct 2021 3:28 PM ISTBengaluru: Biocon Biologics Limited, a subsidiary of Biocon Ltd. has recently announced that Express Scripts, a pharmacy benefit management...
Pandora Papers' wrongly implicates husband's offshore trust: Biocon Chief Kiran Mazumdar Shaw Ruchika Sharma5 Oct 2021 5:00 PM ISTNew Delhi: Kiran Mazumdar-Shaw on Monday said media reports on the 'Pandora Papers' leak have wrongly implicated her husband's offshore trust and...
Biocon launches cancer drug Everolimus in US Ruchika Sharma4 Oct 2021 5:15 PM ISTBengaluru: Global Biopharma company, Biocon Ltd, today announced the expansion of its Generic Formulations portfolio with the launch...
Biocon Biologics gets 6 USFDA observations for Malaysia facility Ruchika Sharma27 Sept 2021 2:10 PM ISTBangalore: Pharma major Biocon has recently announced that the US Food and Drug Administration (USFDA) has concluded an inspection with 6 observations...
Biocon Biologics, Serum Institute Life Sciences enter strategic alliance Ruchika Sharma17 Sept 2021 12:48 PM ISTBengaluru: Biocon Biologics Limited (BBL), a subsidiary of Biocon Ltd. and Serum Institute Life Sciences Private Limited (SILS), a subsidiary of Serum...
Revise Itolizumab phase 3 study protocol for Covid-19: CDSCO panel tells Biocon Medical Dialogues Team13 Sept 2021 5:26 PM ISTNew Delhi: After reviewing Biocon's Phase III trial protocol for Itolizumab for treating Covid-19 patients, the Subject Expert Committee (SEC)...
Biocon, Celgene settle patent litigation over cancer drug Revlimid Ruchika Sharma9 Sept 2021 2:58 PM ISTNew Delhi: Biotechnology major Biocon on Wednesday said it has entered into a settlement with Celgene Corporation regarding patents for Revlimid, a...
Biocon Biologics, Viatris get USFDA nod for first interchangeable biosimilar Semglee for diabetes Ruchika Sharma29 July 2021 1:33 PM ISTThe interchangeable Semglee product, which will allow substitution of Semglee for the reference product, Lantus, at the pharmacy counter, will be...
SEBI slaps Rs 2 lakh fine on Biocon official, bars from securities market for 3 months Ruchika Sharma3 July 2021 12:48 PM ISTNew Delhi: Regulator Sebi has restrained an official of Biocon Ltd from accessing the securities market for three months and also levied monetary...
Biocon Cheif grants Rs 5 crores to Ignite Life Science for research projects on pandemic preparedness Ruchika Sharma10 Jun 2021 2:30 PM ISTBangalore: In support of research projects on "Pandemic Preparedness," Biocon founder and Executive Chairperson Kiran Mazumdar Shaw has announced a...
Insider Trading: Biocon, its designated person slapped Rs 14 lakh fine by SEBI Ruchika Sharma21 May 2021 1:08 PM ISTNew Delhi: Markets regulator Sebi on Wednesday imposed a total fine of Rs 14 lakh on Biocon Ltd and its designated person for violation of market...
